Hope in a pill: drug trial seeks to tame deadly ebola
NCT ID NCT02329054
Summary
This study tested whether a drug called favipiravir could help people survive Ebola Virus Disease. It involved 126 patients in Guinea who received the oral drug. The main goal was to see if the treatment could lower the high death rate associated with Ebola, especially for those treated early after symptoms began.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EBOLA VIRUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ALIMA Ebola care center
Nzérékoré, Guinea
-
French Red Cross Ebola care center
Macenta, Guinea
-
MSF Ebola treatment centre
Gueckedou, Guinea
-
The caregivers treatment center
Conakry, Guinea
Conditions
Explore the condition pages connected to this study.